NO20074087L - Oralt disintegrert sammensetning av olanzapin eller donepezil - Google Patents

Oralt disintegrert sammensetning av olanzapin eller donepezil

Info

Publication number
NO20074087L
NO20074087L NO20074087A NO20074087A NO20074087L NO 20074087 L NO20074087 L NO 20074087L NO 20074087 A NO20074087 A NO 20074087A NO 20074087 A NO20074087 A NO 20074087A NO 20074087 L NO20074087 L NO 20074087L
Authority
NO
Norway
Prior art keywords
olanzapine
donepezil
orally disintegrated
disintegrated composition
composition
Prior art date
Application number
NO20074087A
Other languages
English (en)
Inventor
Renata Jakse
Miha Vrbinc
Vesna Kroselj
Sasa Kolaric
Original Assignee
Krka Tovarna Zdravil Dd Novo M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil Dd Novo M filed Critical Krka Tovarna Zdravil Dd Novo M
Publication of NO20074087L publication Critical patent/NO20074087L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Det er beskrevet oralt desintegrerende preparater av olanzapin eller donepezil som viser en meget rask frigivelse av den aktive bestanddelen, så vel som en fremgangsmåte for fremstilling derav.
NO20074087A 2005-01-14 2007-08-07 Oralt disintegrert sammensetning av olanzapin eller donepezil NO20074087L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05000664A EP1681048A1 (en) 2005-01-14 2005-01-14 Orally disintegrating composition of olanzapine or donepezil
PCT/EP2006/000284 WO2006074951A2 (en) 2005-01-14 2006-01-13 Orally disintegrating composition of olanzapine or donepezil

Publications (1)

Publication Number Publication Date
NO20074087L true NO20074087L (no) 2007-10-09

Family

ID=34933289

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074087A NO20074087L (no) 2005-01-14 2007-08-07 Oralt disintegrert sammensetning av olanzapin eller donepezil

Country Status (15)

Country Link
EP (2) EP1681048A1 (no)
AT (1) ATE465719T1 (no)
AU (1) AU2006205817A1 (no)
DE (1) DE602006013940D1 (no)
DK (1) DK1845954T3 (no)
EA (1) EA013742B1 (no)
ES (1) ES2344959T3 (no)
HR (1) HRP20100399T1 (no)
NO (1) NO20074087L (no)
PL (1) PL1845954T3 (no)
PT (1) PT1845954E (no)
SI (1) SI1845954T1 (no)
UA (1) UA89394C2 (no)
WO (1) WO2006074951A2 (no)
ZA (1) ZA200706692B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879382B2 (en) 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
AU2007232098A1 (en) * 2006-03-31 2007-10-11 Rubicon Research Private Limited Directly compressible composite for orally disintegrating tablets
GB0614586D0 (en) * 2006-07-22 2006-08-30 Pliva Istrazivacki Inst D O O Pharmaceutical Formulation
HUE038022T4 (hu) * 2006-10-02 2023-02-28 Spepharm Ag Nem mukoadhezív filmdózisformák
US7998505B2 (en) * 2006-10-27 2011-08-16 Fmc Corporation Dry granulation binders, products, and use thereof
EP2133096A4 (en) * 2007-03-13 2011-11-16 Dainippon Sumitomo Pharma Co IN THE MOUTHING TABLET
BRPI0817927A2 (pt) 2007-10-01 2015-04-07 Lesvi Laboratorios Sl Comprimidos orodispersiveis
CN101756917A (zh) * 2008-10-24 2010-06-30 北京科信必成医药科技发展有限公司 盐酸多奈哌齐口腔崩解片及其制备方法
WO2010070611A1 (en) * 2008-12-18 2010-06-24 Ranbaxy Laboratories Limited Atazanavir formulations
EP2198857A1 (en) 2008-12-19 2010-06-23 Ratiopharm GmbH Oral dispersible tablet
TR200903293A1 (tr) * 2009-04-28 2010-11-22 Sanovel İlaç San. Ve Ti̇c. A.Ş. Oral yolla dağılan olanzapin tablet.
TR201002084A1 (tr) * 2010-03-19 2011-10-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Oral yolla dağılan donepezil tablet formülasyonları ve hazırlama yöntemi
FR2962331B1 (fr) * 2010-07-06 2020-04-24 Ethypharm Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre
WO2012014012A1 (es) * 2010-07-27 2012-02-02 Laboratorios Andrómaco S.A. Procedimiento para preparar comprimidos de disolucion rapida oral que comprenden la forma i de olanzapina, los comprimidos obtenidos y su uso para el tratamiento de la esquizofrenia.
WO2013052114A1 (en) 2011-10-05 2013-04-11 Fmc Corporation Stabilizer composition of microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
US9055757B2 (en) 2011-10-05 2015-06-16 Fmc Corporation Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
CN103987273B (zh) 2011-12-09 2018-07-27 Fmc有限公司 具有优良胶强度的共磨碎的稳定剂组合物
WO2014027975A2 (en) * 2012-08-17 2014-02-20 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Novel orally administered pharmaceutical formulations
FR2999432B1 (fr) * 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
CN104510717B (zh) * 2013-09-27 2019-02-05 江苏豪森药业集团有限公司 奥氮平口崩片及其制备方法
CN108261399A (zh) * 2016-12-30 2018-07-10 江苏豪森药业集团有限公司 奥氮平口腔崩解片及其制备方法
CN108926543A (zh) * 2017-05-26 2018-12-04 万全万特制药江苏有限公司 一种奥氮平口腔崩解片及其制备方法
CN109498544A (zh) * 2017-09-15 2019-03-22 万全万特制药江苏有限公司 稳定的奥氮平组合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4107842B2 (ja) * 2000-03-01 2008-06-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 ポリビニルアルコールを配合した速崩壊性錠剤
AU2002255196A1 (en) * 2002-04-18 2003-10-27 Dr. Reddy's Laboratories Ltd. Rapidly dispersing solid oral compositions

Also Published As

Publication number Publication date
EP1845954A2 (en) 2007-10-24
ES2344959T3 (es) 2010-09-10
EP1681048A1 (en) 2006-07-19
PL1845954T3 (pl) 2010-10-29
PT1845954E (pt) 2010-08-02
EP1845954B1 (en) 2010-04-28
WO2006074951A2 (en) 2006-07-20
AU2006205817A1 (en) 2006-07-20
UA89394C2 (uk) 2010-01-25
EA200701462A1 (ru) 2008-02-28
ZA200706692B (en) 2008-07-30
WO2006074951A3 (en) 2007-04-26
ATE465719T1 (de) 2010-05-15
SI1845954T1 (sl) 2010-08-31
DK1845954T3 (da) 2010-08-16
EA013742B1 (ru) 2010-06-30
DE602006013940D1 (de) 2010-06-10
HRP20100399T1 (hr) 2010-09-30

Similar Documents

Publication Publication Date Title
NO20074087L (no) Oralt disintegrert sammensetning av olanzapin eller donepezil
TW200621313A (en) Pharmaceutical compositions
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
ECSP066376A (es) FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN
NI201100143A (es) Composición farmacéutica sólida que comprende amlodipina y losartan.
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
WO2007098270A3 (en) Co-crystals comprising vx-950 and pharmaceutical compositions comprising the same
BRPI0711889B8 (pt) método para produção de sinvastatina, composição de matéria, método para fabricação de huvastatina, método para fabricação de sinvastatina, e método para fabricação de uma composição de matéria de sinvastatina ou huvastatina
CL2007003821A1 (es) Compuestos derivados de isoquinolina o isoquinolinona sustituidos con cicloalquilamina; composicion farmaceutica; y su uso para tratar y/o prevenir enfermedades asociadas con la rho-quinasa y/o la fosforilacion mediada por la rho-quinasa de la cadena ligera de miosina, tales como hipertension, retinopatia, glaucoma, alzheimer, sida entre otras.
HN2006014095A (es) Forma cristalina ortorrombica del maleato de asenapina
CR10497A (es) Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor gpr38
EA200601608A1 (ru) Способ производства твёрдой фармацевтической композиции
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
ATE429906T1 (de) Trockene aripiprazolformulierungen
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
ATE519373T1 (de) Teezusammensetzung und herstellungsverfahren dafür
EA201401193A1 (ru) Триарильные соединения и композиции, их содержащие
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
EA200701817A1 (ru) Новые соли 6-гетероциклических замещенных производных гексагидрофенантридина
NI200900207A (es) Una composición de liberación prolongada que comprende un derivado de somatostatina en micropartículas.
WO2006075139A3 (en) Novel process for the preparation of substituted indoles
WO2008137134A3 (en) Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
NO20073046L (no) Utvalgte benzofuranderivater
BRPI0511908A (pt) derivados de aza-biciclo[3.1.0]hex-1-il ativos como antagonistas de nk1

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application